🧫
Literature Review of TRT-Induced Erythrocytosis Risk
active
experiment
Created: 2026-04-06T12:30:12
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-27cb9eed-0a6b-4125-987a-88e2f314d4a4
🧫 Experiment Protocol
Clinicalhypogonadismhuman patientsproposed
A comprehensive literature review examining the relationship between testosterone replacement therapy (TRT) and the development of erythrocytosis and polycythemia in aging males with hypogonadism. The review analyzed available studies to assess the incidence, mechanisms, and risk factors for TRT-induced increases in hemoglobin and hematocrit levels. The study focused on understanding the clinical implications of these hematological changes, particularly in relation to venothromboembolic events, and aimed to provide evidence-based recommendations for monitoring and managing patients receiving TRT. The review examined various TRT formulations, delivery routes, and their differential effects on erythropoiesis.
PRIMARY OUTCOME
incidence of erythrocytosis and polycythemia
EXPECTED OUTCOMES
Documentation of increased risk for erythrocytosis in men receiving TRT and identification of risk factors and mechanisms
SUCCESS CRITERIA
Comprehensive assessment of TRT-related hematological risks and development of clinical recommendations
PROTOCOL
Literature review performed through PubMed database searching for studies on testosterone replacement therapy and erythrocytosis/polycythemia. Analysis of meta-analyses and clinical studies reporting hematological changes following TRT.
Source: PMID 27784544 ↗
🧫 Experiment Extras
PATHWAY
erythropoiesis pathway
MARKET PRICE
$0.50
STATUS
proposed
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.